PROMEDIGEN
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.
PROMEDIGEN
Social Links:
Industry:
Biotechnology Neuroscience
Founded:
2019-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.promedigen.com
Total Employee:
11+
Status:
Active
Contact:
+82 42 867 9113
Email Addresses:
[email protected]
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
GenieUs
GenieUs is a bio-research company that uses the human genome to help neurodegenerative diseases.
Minovia
Minovia is a biotechnology research company focusing on treatment for mitochondrial disease.
Mitosense
Mitosense is a biotechnology company operating in stealth mode.
Neurome
Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases.
ProCore
ProCore is a biotechnology company developing solutions to improve the quality of life of patients suffering from joint and bone diseases.
Senescence Life Sciences
Senescence Life Sciences is a biotechnology company dedicated to redefining and optimizing brain health and performance.
UniXell
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Investors List
Company K Partners
Company K Partners investment in Venture Round - Promedigen
Official Site Inspections
http://www.promedigen.com
- Host name: dot-k1-154.dothome.co.kr
- IP address: 112.175.184.154
- Location: Seongnam-si South Korea
- Latitude: 37.4388
- Longitude: 127.1396
- Timezone: Asia/Seoul
- Postal: 13332
More informations about "Promedigen"
Promedigen - Crunchbase Company Profile & Funding
Promedigen is funded by Company K Partners. When was the last funding round for Promedigen? Promedigen closed its last funding round on Jan 1, 2021 from a Venture - Series Unknown …See details»
Promedigen Company Profile 2024: Valuation, Funding
Promedigen General Information Description. Operator of a biotechnology company intended to treat cancer and neurodegenerative disorders. The company specializes in providing …See details»
Promedigen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Promedigen, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Promedigen - VentureRadar
PROMEDIGEN has developed a unique, proprietary technology platform for site-specific introduction of PTMs. This technology enables production of abnormally modified proteins that …See details»
Promedigen - Funding, Financials, Valuation & Investors
Jan 1, 2021 Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Promedigen - Products, Competitors, Financials, Employees, …
Promedigen is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. Use the CB Insights Platform to explore Promedigen's full …See details»
Promedigen - Crunchbase
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
Promedigen Inc. Company Profile - Dun & Bradstreet
Promedigen Inc. Company Profile | Daejeon, Daejeon, Republic Of Korea | Competitors, Financials & Contacts - Dun & BradstreetSee details»
프로메디젠 주식회사 - PROMEDIGEN
Team Organization – Expanding with Highly Experienced Consultants . Summary and Next Steps • As a VC VC-backed, ... • Promedigen to use proprietary platform to progress targets as …See details»
Promedigen Company Profile - Selligence
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
Promedigen | VentureRadar
PROMEDIGEN has developed a unique, proprietary technology platform for site-specific introduction of PTMs. This technology enables production of abnormally modified proteins that …See details»
프로메디젠 주식회사 - PROMEDIGEN
PROMEDIGEN’s core technology enables production of disease-specific PPI models by selective phosphorylation and custom-made PTMs. ① Evolved SepRS produces phosphoseryl tRNA. …See details»
Promedigen - Updates, News, Events, Signals & Triggers
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
Promedigen - YouTube
PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
PROMEDIGEN Introduction video - YouTube
Jul 24, 2022 PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.Visit our website and learn about PR...See details»
프로메디젠 주식회사 - PROMEDIGEN
However, PROMEDIGEN's technology enables targeting any disease-associated PPI. Proteins are expressed and purified from bacterial culture, and PTMs are site-specifically introduced. …See details»
Promedigen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Promedigen is actively using 17 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible , Viewport Meta , and SPF . Website Tech Stack by BuiltWithSee details»
프로메디젠 주식회사 - PROMEDIGEN
"프로메디젠, 세계 최초 종양억제인자 활성화 성공" 프로메디젠 기업부설연구소 신약개발팀이 세계 최초로 종양 억제 인자 활성화에 성공, 전이성 암을 치료하는 길을 열었다고 25일 밝혔다.See details»
프로메디젠 주식회사 - PROMEDIGEN
프로메디젠 주식회사 - PROMEDIGEN ... 설명See details»